GYRE THERAPEUTICS, INC. (GYRE) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US4037831033
GYRE THERAPEUTICS, INC. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 116.59 m USD |
| Gross profit | 111.17 m USD |
| Operating income | 11.49 m USD |
| EBIT | 19.29 m USD |
| Net income | 9.88 m USD |
| Diluted EPS – continuing operations | 0.02 USD |
Full history since 2001, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About GYRE THERAPEUTICS, INC.
Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis. The company offers ETUARY (Pirfenidone), an anti-fibrotic drug approved for the treatment of idiopathic pulmonary fibrosis; and under Phase 3 trials for the treatment of pneumoconiosis. It is also involved in the development of F351 (Hydronidone), a structural derivative of ETUARY under Phase 3 trials for the treatment of chronic hepatitis B (CHB)-associated liver fibrosis; and completed Phase 1 trials for the treatment of liver fibrosis associated with metabolic dysfunction-associated steatohepatitis. In addition, the company develops F573, which is in Phase 2 clinical trials for the treatment of acute/acute-on-chronic liver failure. Further, its preclinical products include F230 for the treatment of pulmonary arterial hypertension; and F528 to treat chronic obstructive pulmonary disease. Gyre Therapeutics, Inc. was founded in 2002 and is headquartered in San Diego, California. Gyre Therapeutics, Inc. operates as a subsidiary of GNI USA, Inc.
More stocks
- AVITA Medical, Inc. (RCEL)
- Alpha Teknova, Inc. (TKNO)
- Posti Group Oyj (POSTI.HE)
- Wuhan Kotei Informatics Co.Ltd. (301221.SZ)
- Guangdong Brandmax Marketing Co Ltd (300805.SZ)
- Singapore Post Ltd (S08.SI)
- TELOS CORP (TLS)
- Porvair PLC (PRV.L)
- Oportun Financial Corp (OPRT)
- TrueLight (3234.TWO)
- Ponce Financial Group, Inc. (PDLB)
- Orange County Bancorp, Inc. /DE/ (OBT)
Not investment advice. All data without warranty, price as of 09.11.2026. Details in the risk notice.